[1] D'SOUZA A,FRETHAM C,LEE S J,et al.Current use of and trends in hematopoietic cell transplantation in the United States[J].Biol Blood Marrow Transplant,2020,26(8):e177-e182. [2] ZAUCHA J M,GOOLEY T,BENSINGER W I,et al.CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation[J].Blood,2001,98(12):3221-3227. [3] MOHTY M,BILGER K,JOURDAN E,et al.Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation[J].Leukemia,2003,17(5):869-875. [4] 陈岑,齐瑛,程文晋,等.MCS+LDP和UPP程序单采血小板效果对比分析[J].检验医学与临床,2021,18(18):2663-2666. [5] DIMA F,BARISON E,MIDOLO M,et al.Assessment of haematopoietic progenitor cell counting with the Sysmex® XN-1000 to guide timing of apheresis of peripheral blood stem cells[J].Blood Transfus,2020,18(1):67-76. [6] PEREA G,SUREDA A,MARTINO R,et al.Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma[J].Ann Hematol,2001,80(10):592-597. [7] LYSÁK D,KOZA V,JINDRA P.Factors affecting PBSC mobilization and collection in healthy donors[J].Transfus Apher Sci,2005,33(3):275-283. [8] ZUBAIR A C,GRANT R,WU W T,et al.Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients[J].Transfusion,2008,48(6):1106-1114. [9] DELONG E R,DELONG D M,CLARKE-PEARSON D L.Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach[J].Biometrics,1988,44(3):837-845. [10] RAY G K,JENA R K,PANDA T,et al.Prospective identification of potential factors influencing stem cell mobilization and the necessity for plerixafor use in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation[J].Hematol Transfus Cell Ther,2021,43(4):402-409. [11] 管方舒,何冬花,李奕,等.普乐沙福联合G-CSF动员淋巴瘤患者自体外周血造血干细胞的疗效及安全性分析[J].中国实验血液学杂志,2023,31(4):1056-1060. [12] KOZUKA T,IKEDA K,TESHIMA T,et al.Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors[J].Transfusion,2004,44(4):526-532. [13] PUSIC I,JIANG S Y,LANDUA S,et al.Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation[J].Biol Blood Marrow Transplant,2008,14(9):1045-1056. [14] 李少文,朱展鸿,郭楚霞,等.外周血造血干细胞单采影响因素及时机预测的探讨[J].中国输血杂志,2021,34(8):843-846. [15] KONG J H,HU Y M,SHIM H,et al.Analysis of factors associated with successful allogeneic peripheral blood stem cell collection in healthy donors[J].Transfus Apher Sci,2020,59(2):102679. [16] 苗莹莹,张根玲,冉茜,等.健康供者异基因外周血造血干细胞移植采集因素分析[J].中国输血杂志,2020,33(9):914-917. |